Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Effective repositioning maneuvers for dizziness after stroke

Official title: Effectiveness of Epley Maneuver Versus Semont Maneuver on Dizziness and Balance in Stroke Survivors With Posterior Canal Benign Paroxysmal Positional Vertigo: A Randomized Controlled Trial

Run by Ibadat International University, Islamabad · NCT07887191 · Data updated 2026-11-12

This study tests whether the Epley maneuver works better or worse than the Semont maneuver for reducing dizziness and improving balance in stroke survivors with posterior canal BPPV.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorIbadat International University, Islamabad
Academic / other
Locations1 site (Rawalpindi, Punjab Province)
StatusRecruiting
StartedJune 3, 2026
Main results expectedNovember 30, 2026
Study endsDecember 5, 2026
Registry record updatedOctober 21, 2026
Trial IDNCT07887191 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with a history of stroke who have posterior canal BPPV confirmed by Dix-Hallpike testing and are able to sit or walk with or without support and participate in treatment sessions.

Probably not a fit

Patients who do not have posterior canal BPPV or who cannot safely undergo the repositioning maneuvers may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized trial, adults who have had a stroke and are diagnosed with posterior canal BPPV will be assigned to receive either the Epley or the Semont maneuver. Dizziness severity and balance will be measured at baseline, 2 weeks, and 4 weeks using the DHI, BBS, and Dix-Hallpike test. The goal is to see which maneuver more effectively relieves vertigo symptoms and improves stability over a short follow-up period. Results may help physiotherapists choose the more beneficial treatment for this patient group.

Why it matters

Potential benefit: If successful, this could help clinicians pick the most effective maneuver to reduce dizziness and improve balance in stroke survivors with posterior canal BPPV.

How similar studies have gone: Previous research supports repositioning maneuvers for BRPV in the general population, but evidence specifically in stroke survivors is limited, making this a relatively targeted investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: above 18years Diagnosed with stroke survivors Diagnosed with posterior canal BPPV via Dix-Hallpike Test Functional status: Able to sit or walk with/without support, follow instructions, and participate in treatment sessions Willing to participate

Exclusion Criteria:

* Other vestibular disorders (e.g., Meniere's disease (inner ear disorder causing vertigo, hearing loss, and tinnitus)) Diagnosed cognitive impairment (unable to follow instructions) Medically unstable patients Severe cervical spine disorders (e.g., instability, fracture) Spinal conditions restricting head movement Completely bed-bound patients Any contraindication to Dix Hallpike repositioning maneuvers

Where it's running

  • Afirm
    Rawalpindi, Punjab Province, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Somiya Naz, BSPT, PPDPT, PHD Scholar — Ibadat International University
  • Study coordinator: Dr. Somiya Naz, BSPT, PPDPT, PHD Scholar
  • Email: dr.somiyanaz@gmail.com
  • Phone: 923315163093

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.